Skip to main content
Equibles

MARSHALL WACE, LLP

Position in IMVT — Immunovant, Inc.

CIK 1318757 LONDON, X0
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,490,062
+$1,384,010 QoQ
Shares Held
142,488
-13.8% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#53
of 226 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. IMVT ranks #99 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 543,897 $270,169,956
2 INCY
Incyte Corp
 1,310,154 $148,519,056
3 RPRX
Royalty Pharma plc
 2,450,669 $137,409,009
4 SYRE
Spyre Therapeutics, Inc.
 991,693 $88,042,503
5 ALNY
Alnylam Pharmaceuticals, Inc.
 259,799 $78,207,292
6 TVTX
Travere Therapeutics, Inc.
 1,333,207 $75,739,488
7 MANE
Veradermics, Inc
 585,560 $71,988,746
8 DFTX
Definium Therapeutics, Inc.
 1,298,946 $61,102,419

All Filings in IMVT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,490,062 142,488
2026-03-31 $4,106,052 165,300
2025-09-30 $6,765,240 419,680
2025-03-31 $2,366,571 138,477
2024-09-30 $3,253,105 114,104
2024-03-31 $1,729,651 53,533
2023-09-30 $226,501 5,900
2022-12-31 $691,415 38,953
2021-12-31 $70,852 8,316
2021-09-30 $632,823 72,822
2021-06-30 $181,455 17,167
2021-03-31 $339,951 21,194
2020-12-31 $251,966 5,455
2020-06-30 $1,546,492 63,511
2020-03-31 $171,775 11,036